| Eric A Pena, MD FACC | |
|
520 Medical Center Dr, Suite 200, Medford, OR 97504-4314 | |
| (541) 282-6606 | |
| (541) 282-6601 |
| Full Name | Eric A Pena |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 34 Years |
| Location | 520 Medical Center Dr, Medford, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093703563 | NPI | - | NPPES |
| 227007 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0001X | Internal Medicine - Clinical Cardiac Electrophysiology | 24394 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Asante Rogue Regional Medical Center | Medford, OR | Hospital |
| Asante Three Rivers Medical Center | Grants pass, OR | Hospital |
| Asante Ashland Community Hospital | Ashland, OR | Hospital |
| Curry General Hospital | Gold beach, OR | Hospital |
| Sky Lakes Medical Center | Klamath falls, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Asante | 0547177321 | 88 |
| Southern Oregon Cardiology Llc | 2264572510 | 26 |
| Asante Ashland Community Hospital Llc | 7012286859 | 40 |
| Asante Three Rivers Medical Center Llc | 9931197993 | 80 |
News Archive
Today, U.S. regulators and representatives from national food production industries will meet to discuss "Improving Antimicrobial Use in Food Animal Production: Alternatives, Options and Incentives," in Washington, DC.
The Supreme Court was asked on Wednesday to hear a challenge to the health care overhaul law, raising the possibility that the justices could rule on the matter by next summer, just months before the presidential election.
The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.
A multi-faceted treatment program for young adults addicted to opioid drugs was unveiled today at the National Institute on Drug Abuse's Blending Conference in Albuquerque, N.M. This eighth meeting in the series brings together researchers and clinicians so their latest findings can be immediately applied to the needs of patients and their families dealing with addictive disorders.
A new drug has shown promising results against breast and prostate cancer cells and tumours that are resistant to conventional hormone-based treatments, according to research published in the British Journal of Cancer.
› Verified 7 days ago
| Entity Name | Asante |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770587107 PECOS PAC ID: 0547177321 Enrollment ID: O20031219000238 |
News Archive
Today, U.S. regulators and representatives from national food production industries will meet to discuss "Improving Antimicrobial Use in Food Animal Production: Alternatives, Options and Incentives," in Washington, DC.
The Supreme Court was asked on Wednesday to hear a challenge to the health care overhaul law, raising the possibility that the justices could rule on the matter by next summer, just months before the presidential election.
The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.
A multi-faceted treatment program for young adults addicted to opioid drugs was unveiled today at the National Institute on Drug Abuse's Blending Conference in Albuquerque, N.M. This eighth meeting in the series brings together researchers and clinicians so their latest findings can be immediately applied to the needs of patients and their families dealing with addictive disorders.
A new drug has shown promising results against breast and prostate cancer cells and tumours that are resistant to conventional hormone-based treatments, according to research published in the British Journal of Cancer.
› Verified 7 days ago
| Entity Name | Asante Three Rivers Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801891809 PECOS PAC ID: 9931197993 Enrollment ID: O20040506000367 |
News Archive
Today, U.S. regulators and representatives from national food production industries will meet to discuss "Improving Antimicrobial Use in Food Animal Production: Alternatives, Options and Incentives," in Washington, DC.
The Supreme Court was asked on Wednesday to hear a challenge to the health care overhaul law, raising the possibility that the justices could rule on the matter by next summer, just months before the presidential election.
The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.
A multi-faceted treatment program for young adults addicted to opioid drugs was unveiled today at the National Institute on Drug Abuse's Blending Conference in Albuquerque, N.M. This eighth meeting in the series brings together researchers and clinicians so their latest findings can be immediately applied to the needs of patients and their families dealing with addictive disorders.
A new drug has shown promising results against breast and prostate cancer cells and tumours that are resistant to conventional hormone-based treatments, according to research published in the British Journal of Cancer.
› Verified 7 days ago
| Entity Name | Southern Oregon Cardiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033444781 PECOS PAC ID: 2264572510 Enrollment ID: O20091216000502 |
News Archive
Today, U.S. regulators and representatives from national food production industries will meet to discuss "Improving Antimicrobial Use in Food Animal Production: Alternatives, Options and Incentives," in Washington, DC.
The Supreme Court was asked on Wednesday to hear a challenge to the health care overhaul law, raising the possibility that the justices could rule on the matter by next summer, just months before the presidential election.
The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.
A multi-faceted treatment program for young adults addicted to opioid drugs was unveiled today at the National Institute on Drug Abuse's Blending Conference in Albuquerque, N.M. This eighth meeting in the series brings together researchers and clinicians so their latest findings can be immediately applied to the needs of patients and their families dealing with addictive disorders.
A new drug has shown promising results against breast and prostate cancer cells and tumours that are resistant to conventional hormone-based treatments, according to research published in the British Journal of Cancer.
› Verified 7 days ago
| Entity Name | Asante Ashland Community Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730628827 PECOS PAC ID: 7012286859 Enrollment ID: O20180426001620 |
News Archive
Today, U.S. regulators and representatives from national food production industries will meet to discuss "Improving Antimicrobial Use in Food Animal Production: Alternatives, Options and Incentives," in Washington, DC.
The Supreme Court was asked on Wednesday to hear a challenge to the health care overhaul law, raising the possibility that the justices could rule on the matter by next summer, just months before the presidential election.
The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.
A multi-faceted treatment program for young adults addicted to opioid drugs was unveiled today at the National Institute on Drug Abuse's Blending Conference in Albuquerque, N.M. This eighth meeting in the series brings together researchers and clinicians so their latest findings can be immediately applied to the needs of patients and their families dealing with addictive disorders.
A new drug has shown promising results against breast and prostate cancer cells and tumours that are resistant to conventional hormone-based treatments, according to research published in the British Journal of Cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric A Pena, MD FACC 520 Medical Center Dr, Suite 200, Medford, OR 97504-4314 Ph: (541) 282-6606 | Eric A Pena, MD FACC 520 Medical Center Dr, Suite 200, Medford, OR 97504-4314 Ph: (541) 282-6606 |
News Archive
Today, U.S. regulators and representatives from national food production industries will meet to discuss "Improving Antimicrobial Use in Food Animal Production: Alternatives, Options and Incentives," in Washington, DC.
The Supreme Court was asked on Wednesday to hear a challenge to the health care overhaul law, raising the possibility that the justices could rule on the matter by next summer, just months before the presidential election.
The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.
A multi-faceted treatment program for young adults addicted to opioid drugs was unveiled today at the National Institute on Drug Abuse's Blending Conference in Albuquerque, N.M. This eighth meeting in the series brings together researchers and clinicians so their latest findings can be immediately applied to the needs of patients and their families dealing with addictive disorders.
A new drug has shown promising results against breast and prostate cancer cells and tumours that are resistant to conventional hormone-based treatments, according to research published in the British Journal of Cancer.
› Verified 7 days ago
Helen Koenigsman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1333 E Barnett Rd, Medford, OR 97504 Phone: 541-779-4711 | |
Dr. Todd S Kotler, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 520 Medical Center Drive, Ste 200, Medford, OR 97504 Phone: 541-282-6606 Fax: 541-282-6601 | |
Dr. Mark G Moran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 Medical Center Drive, Ste 200, Medford, OR 97504 Phone: 541-282-6606 Fax: 541-282-6601 | |
Dr. June Symens, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 555 Black Oak Dr Ste 400, Medford, OR 97504 Phone: 541-821-6090 | |
Donald L Bowser, NP Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 520 Medical Center Dr, Suite 100, Medford, OR 97504 Phone: 541-789-5704 Fax: 541-789-5989 | |
Samridhi Amba, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 827 Spring St, Medford, OR 97504 Phone: 541-732-7600 | |
Margaret Sara Fairhurst, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1698 E Mcandrews Rd Ste 400, Medford, OR 97504 Phone: 541-732-7960 |